375 related articles for article (PubMed ID: 18445652)
1. Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells.
Sonoda N; Imamura T; Yoshizaki T; Babendure JL; Lu JC; Olefsky JM
Proc Natl Acad Sci U S A; 2008 May; 105(18):6614-9. PubMed ID: 18445652
[TBL] [Abstract][Full Text] [Related]
2. GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells.
Quoyer J; Longuet C; Broca C; Linck N; Costes S; Varin E; Bockaert J; Bertrand G; Dalle S
J Biol Chem; 2010 Jan; 285(3):1989-2002. PubMed ID: 19915011
[TBL] [Abstract][Full Text] [Related]
3. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
Estall JL; Koehler JA; Yusta B; Drucker DJ
J Biol Chem; 2005 Jun; 280(23):22124-34. PubMed ID: 15817468
[TBL] [Abstract][Full Text] [Related]
4. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.
Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR
J Biol Chem; 2021; 296():100133. PubMed ID: 33268378
[TBL] [Abstract][Full Text] [Related]
5. β-Arrestin1-mediated recruitment of c-Src underlies the proliferative action of glucagon-like peptide-1 in pancreatic β INS832/13 cells.
Talbot J; Joly E; Prentki M; Buteau J
Mol Cell Endocrinol; 2012 Nov; 364(1-2):65-70. PubMed ID: 22939843
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles for β-arrestin-1 in the control of the pancreatic β-cell function and mass: new therapeutic strategies and consequences for drug screening.
Dalle S; Ravier MA; Bertrand G
Cell Signal; 2011 Mar; 23(3):522-8. PubMed ID: 20849951
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells.
Zhang M; Robitaille M; Showalter AD; Huang X; Liu Y; Bhattacharjee A; Willard FS; Han J; Froese S; Wei L; Gaisano HY; Angers S; Sloop KW; Dai FF; Wheeler MB
Mol Cell Proteomics; 2014 Nov; 13(11):3049-62. PubMed ID: 25044020
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
Ma X; Guan Y; Hua X
J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
[TBL] [Abstract][Full Text] [Related]
9. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS; Jun HS
Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
[TBL] [Abstract][Full Text] [Related]
10. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
11. miR-7 Regulates GLP-1-Mediated Insulin Release by Targeting β-Arrestin 1.
Matarese A; Gambardella J; Lombardi A; Wang X; Santulli G
Cells; 2020 Jul; 9(7):. PubMed ID: 32640511
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis.
Linnemann AK; Neuman JC; Battiola TJ; Wisinski JA; Kimple ME; Davis DB
Mol Endocrinol; 2015 Jul; 29(7):978-87. PubMed ID: 25984632
[TBL] [Abstract][Full Text] [Related]
13. beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1.
Usui I; Imamura T; Huang J; Satoh H; Shenoy SK; Lefkowitz RJ; Hupfeld CJ; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(20):8929-37. PubMed ID: 15456867
[TBL] [Abstract][Full Text] [Related]
14. Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells.
Roger B; Papin J; Vacher P; Raoux M; Mulot A; Dubois M; Kerr-Conte J; Voy BH; Pattou F; Charpentier G; Jonas JC; Moustaïd-Moussa N; Lang J
Diabetologia; 2011 Feb; 54(2):390-402. PubMed ID: 21046358
[TBL] [Abstract][Full Text] [Related]
15. The identification of novel proteins that interact with the GLP-1 receptor and restrain its activity.
Huang X; Dai FF; Gaisano G; Giglou K; Han J; Zhang M; Kittanakom S; Wong V; Wei L; Showalter AD; Sloop KW; Stagljar I; Wheeler MB
Mol Endocrinol; 2013 Sep; 27(9):1550-63. PubMed ID: 23864651
[TBL] [Abstract][Full Text] [Related]
16. Subthreshold α₂-adrenergic activation counteracts glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion.
Pan M; Yang G; Cui X; Yang SN
Exp Diabetes Res; 2011; 2011():604989. PubMed ID: 21253359
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of dimethyl sulfoxide on glucagon-like peptide 1 (GLP-1)-stimulated insulin secretion and gene transcription in INS-1 cells: characterization and implications.
Kemp DM; Habener JF
Biochem Pharmacol; 2002 Aug; 64(4):689-97. PubMed ID: 12167488
[TBL] [Abstract][Full Text] [Related]
18. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation.
Liu Z; Habener JF
J Biol Chem; 2008 Mar; 283(13):8723-35. PubMed ID: 18216022
[TBL] [Abstract][Full Text] [Related]
20. Cav1.2 and Cav1.3 are differentially coupled to glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1.
Jacobo SM; Guerra ML; Hockerman GH
J Pharmacol Exp Ther; 2009 Nov; 331(2):724-32. PubMed ID: 19710366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
